Par Drugs and Chemicals Ltd

PAR

Company Profile

  • Business description

    Par Drugs and Chemicals Ltd manufactures active Pharmaceutical Ingredients (APIs) and fine chemicals, serving domestic and international markets. Specializing in essential magnesium-based compounds and other specialty chemicals such as Magnesium Hydroxide, Magnesium Trisilicate, Magnesium Carbonate, various grades of Magnesium Oxide, Dried Aluminum Hydroxide Gel, and Sucralfate USP, the Company produces high-quality bulk drugs used in the formulation of finished pharmaceutical products like tablets, capsules, and liquids. Committed to maintaining stringent quality standards and utilizing manufacturing processes, the Company plays a vital role in supplying reliable ingredients that ensure the safety, efficacy, and stability of pharmaceutical formulations internationally.

  • Contact

    Gotri Vasna Road
    815, Nilamber Triumph
    VadodaraGJ390007
    IND

    T: +91 2652991021

    https://www.pardrugs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    121

Stocks News & Analysis

stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.
stocks

Undervalued ASX share searches for cost savings

Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks

Chart of the Week: Where we see opportunities after year end market sell-off

The latest insights from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,983.3028.900.32%
CAC 408,068.6217.14-0.21%
DAX 4024,186.49108.12-0.45%
Dow JONES (US)48,458.05245.96-0.51%
FTSE 1009,649.0354.13-0.56%
HKSE25,976.79446.281.75%
NASDAQ23,195.17398.69-1.69%
Nikkei 22550,836.55687.731.37%
NZX 50 Index13,406.9111.040.08%
S&P 5006,827.4173.59-1.07%
S&P/ASX 2008,697.3032.400.37%
SSE Composite Index3,889.3516.030.41%

Market Movers